Cook Benjamin Lê, Flores Michael, Progovac Ana M, Moyer Margo, Holmes Katie E, Lê Thomas, Kumar Anika, Levy Douglas, Saloner Brendan, Wayne Geoff Ferris
Harvard Medical School, Department of Psychiatry, Boston, Massachusetts; Cambridge Health Alliance Health Equity Research Lab, Cambridge, Massachusetts.
Harvard Medical School, Department of Psychiatry, Boston, Massachusetts; Cambridge Health Alliance Health Equity Research Lab, Cambridge, Massachusetts.
Am J Prev Med. 2025 Mar;68(3):485-496. doi: 10.1016/j.amepre.2024.11.010. Epub 2024 Nov 28.
Many U.S. states expanded the generosity of Medicaid insurance coverage of tobacco dependence treatment over the last fifteen years, but little is known about how coverage impacts cigarette smoking, especially for individuals with substance use disorder.
Data are from the 2009 to 2018 National Survey on Drug Use and Health and include Medicaid beneficiaries 18-64 years old with past year substance use disorder who smoked at least 100 cigarettes in their lifetime. Outcomes were smoking cessation, nicotine dependence, and number of cigarettes smoked per month. Difference-in-differences models were estimated for smoking behavior by state and year of comprehensive tobacco dependence treatment coverage, estimating multivariable linear probability models, adjusted for sociodemographic characteristics, co-occurring mental illness, and area-level provider supply. All data were analyzed in 2023 and 2024.
Rates of nicotine dependence among individuals with past-year SUD increased slightly between 2009 and 2018 among individuals living in states with comprehensive tobacco dependence treatment coverage (55.6% to 58.6%) and changed little among individuals living in states with no or partial TDT coverage (60.0% to 59.5%). Quit rates increased for individuals with substance use disorder during this time, with no differences by comprehensive tobacco dependence treatment coverage. In adjusted models, no significant association between comprehensive Medicaid tobacco dependence treatment coverage and smoking behaviors was identified (e.g., cessation: β= -0.02, CI=-0.08, 0.04). One-year lagged outcomes and sensitivity analyses accounting for the differential time of initiation of state policies demonstrated similar results.
Comprehensive tobacco dependence treatment coverage had no differential effect on smoking cessation among ever smokers with or without substance use disorder, and its expansion was not associated with changes in smoking behaviors for Medicaid beneficiaries with substance use disorder. Other multilevel interventions may be needed to impact smoking cessation rates, such as awareness and education campaigns of expanded tobacco dependence treatment coverage benefits, and interventions that reduce social and structural barriers to treatment.
在过去十五年中,美国许多州扩大了医疗补助保险对烟草依赖治疗的覆盖范围,但对于这种覆盖范围如何影响吸烟情况,尤其是对患有物质使用障碍的个体,人们了解甚少。
数据来自2009年至2018年的全国药物使用和健康调查,包括年龄在18至64岁、过去一年患有物质使用障碍且一生至少吸过100支香烟的医疗补助受益人。结果指标为戒烟情况、尼古丁依赖程度以及每月吸烟量。通过州和全面烟草依赖治疗覆盖年份对吸烟行为进行差分模型估计,估计多变量线性概率模型,并根据社会人口学特征、共病精神疾病和地区层面的医疗服务提供者供应情况进行调整。所有数据于2023年和2024年进行分析。
在2009年至2018年期间,居住在拥有全面烟草依赖治疗覆盖的州的过去一年患有物质使用障碍的个体中,尼古丁依赖率略有上升(从55.6%升至58.6%),而居住在没有或部分有烟草依赖治疗覆盖的州的个体中,该比率变化不大(从60.0%降至59.5%)。在此期间,患有物质使用障碍的个体的戒烟率有所上升,全面烟草依赖治疗覆盖与否并无差异。在调整后的模型中,未发现全面医疗补助烟草依赖治疗覆盖与吸烟行为之间存在显著关联(例如,戒烟:β = -0.02,置信区间=-0.08,0.04)。一年滞后结果和考虑州政策启动时间差异的敏感性分析显示了类似结果。
全面烟草依赖治疗覆盖对有或无物质使用障碍的曾经吸烟者的戒烟情况没有差异影响,其扩大与患有物质使用障碍的医疗补助受益人的吸烟行为变化无关。可能需要其他多层次干预措施来影响戒烟率,例如开展关于扩大烟草依赖治疗覆盖福利的宣传和教育活动,以及减少治疗的社会和结构障碍的干预措施。